Laura Shawver - Net Worth and Insider Trading
Laura Shawver Net Worth
The estimated net worth of Laura Shawver is at least $2 Million dollars as of 2024-12-27. Laura Shawver is the Director of ARS Pharmaceuticals Inc and owns about 210,346 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $2 Million. Details can be seen in Laura Shawver's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laura Shawver has not made any transactions after 2024-12-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laura Shawver
Laura Shawver Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura Shawver owns 5 companies in total, including Relay Therapeutics Inc (RLAY) , Nkarta Inc (NKTX) , and Synthorx Inc (THOR) among others .
Click here to see the complete history of Laura Shawver’s form 4 insider trades.
Insider Ownership Summary of Laura Shawver
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RLAY | Relay Therapeutics Inc | 2020-07-15 | director |
NKTX | Nkarta Inc | 2020-07-09 | director |
THOR | Synthorx Inc | 2020-01-23 | director & President and CEO |
2020-12-03 | director & Chief Executive Officer | ||
2024-12-04 | director & Chief Executive Officer |
Laura Shawver Latest Holdings Summary
Laura Shawver currently owns a total of 1 stock. Laura Shawver owns 210,346 shares of ARS Pharmaceuticals Inc (SPRY) as of December 4, 2024, with a value of $2 Million.
Latest Holdings of Laura Shawver
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SPRY | ARS Pharmaceuticals Inc | 2024-12-04 | 210,346 | 11.15 | 2,345,358 |
Holding Weightings of Laura Shawver
Laura Shawver Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura Shawver has made a total of 8 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 200,000 shares on December 4, 2024, which brought Laura Shawver around $3 Million.
Insider Trading History of Laura Shawver
- 1
Laura Shawver Trading Performance
Laura Shawver Ownership Network
Laura Shawver Owned Company Details
What does Relay Therapeutics Inc do?
Who are the key executives at Relay Therapeutics Inc?
Laura Shawver is the director of Relay Therapeutics Inc. Other key executives at Relay Therapeutics Inc include director & President and CEO Sanjiv Patel , Vice President & Finance Thomas Catinazzo , and See remarks Peter Rahmer .
Relay Therapeutics Inc (RLAY) Insider Trades Summary
Over the past 18 months, Laura Shawver made no insider transaction in Relay Therapeutics Inc (RLAY). Other recent insider transactions involving Relay Therapeutics Inc (RLAY) include a net sale of 131,867 shares made by Peter Rahmer , a net sale of 43,738 shares made by Thomas Catinazzo , and a net sale of 17,892 shares made by Donald A Bergstrom .
In summary, during the past 3 months, insiders sold 115,043 shares of Relay Therapeutics Inc (RLAY) in total and bought 0 shares, with a net sale of 115,043 shares. During the past 18 months, 389,882 shares of Relay Therapeutics Inc (RLAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 389,882 shares.
Relay Therapeutics Inc (RLAY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relay Therapeutics Inc Insider Transactions
Laura Shawver Mailing Address
Above is the net worth, insider trading, and ownership report for Laura Shawver. You might contact Laura Shawver via mailing address: 1255 Crescent Green Drive, Suite 250, Cary Nc 27518.